Empower Advisory Group
NVO

Empower Advisory Group’s Novo Nordisk NVO Stock Holding History

Empower Advisory Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$222K Buy
+4,632
New +$199K ﹤0.01% 495
2025
Q4 		– Sell
-5,817
Closed -$323K – 531
2025
Q3 		$323K Sell
5,817
-276
-5% -$16.2K ﹤0.01% 415
2025
Q2 		$421K Sell
6,093
-4,549
-43% -$309K ﹤0.01% 346
2025
Q1 		$739K Sell
10,642
-1,809
-15% -$149K ﹤0.01% 267
2024
Q4 		$1.07M Sell
12,451
-280
-2% -$30.3K ﹤0.01% 232
2024
Q3 		$1.52M Sell
12,731
-289
-2% -$38.5K 0.01% 209
2024
Q2 		$1.86M Buy
13,020
+77
+0.6% +$10.2K 0.01% 202
2024
Q1 		$1.66M Buy
12,943
+948
+8% +$113K 0.01% 210
2023
Q4 		$1.24M Buy
11,995
+1,582
+15% +$156K ﹤0.01% 225
2023
Q3 		$947K Sell
10,413
-1,333
-11% -$117K ﹤0.01% 233
2023
Q2 		$950K Buy
11,746
+450
+4% +$36.8K ﹤0.01% 238
2023
Q1 		$901K Buy
+11,296
New +$801K ﹤0.01% 247

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Empower Advisory Group's NVO Position: Q2 2026 in Review

Empower Advisory Group opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,632 shares worth $222K. The stake represents ﹤0.01% of the portfolio and ranks #495 among its holdings. This is a return to the name: Empower Advisory Group previously reported a position in NVO as recently as Q3 2025.

Empower Advisory Group first reported a position in NVO in Q1 2023 and has held it in 12 quarters since. The position peaked at $1.86M in Q2 2024. 1,354 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Empower Advisory Group held 4,632 shares of Novo Nordisk worth $222K as of Q2 2026.
  • Novo Nordisk was a new Empower Advisory Group position in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of Empower Advisory Group's portfolio in Q2 2026, its #495 holding.
  • Empower Advisory Group first reported a position in Novo Nordisk in Q1 2023 and has held it in 12 quarters since.
  • Empower Advisory Group's Novo Nordisk position peaked at $1.86M in Q2 2024.
  • 1,354 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Empower Advisory Group's 13F filing for Q2 2026, filed 12 Aug 2026.